Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy

Trial Profile

A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 22 May 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ARRY 797 (Primary)
  • Indications Dilated cardiomyopathy
  • Focus Therapeutic Use
  • Sponsors Array BioPharma
  • Most Recent Events

    • 30 Aug 2016 Results published in Array BioPharma media release.
    • 01 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 03 May 2016 Results from this trial will be presented at the European Society of Cardiology, according to an Array BioPharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top